NCT06416163View on ClinicalTrials.gov

FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion

Not yet recruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

October 1, 2028

Study Completion Date

July 1, 2029

Conditions
Interstitial Lung DiseaseFibrosis LungPulmonary Hypertension
Interventions
OTHER

Prospective

Collection of prospective data all ready available for participant

Trial Locations (1)

SE1 9RT

Guy's & St Thomas' NHS Foundation Trust, London

All Listed Sponsors
lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT06416163 - FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion | Biotech Hunter | Biotech Hunter